A world-class specialty pharmaceutical company
Our ambition is to become a leading specialty pharmaceutical company meeting the needs of patients around the world. With our portfolio of respiratory products we’re making good progress towards achieving our goal.
- Circassia Announces Duaklir® US Launch at American College of Chest Physicians’ CHEST Annual Meeting 2019
- Interim results for the six months ended 30 June 2019
- Circassia Appoints Industry Veteran Jonathan Emms as Chief Operating Officer